A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
Clinical trial NCT02760264 · COMPLETED
Trial details
- NCT number
- NCT02760264
- Sponsor
- ReveraGen BioPharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2018-05-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.